Ultragenyx Pharmaceutical Statistics
Total Valuation
RARE has a market cap or net worth of $3.51 billion. The enterprise value is $3.83 billion.
Important Dates
The next estimated earnings date is Thursday, July 31, 2025, after market close.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RARE has 94.38 million shares outstanding. The number of shares has increased by 21.44% in one year.
| Current Share Class | 94.38M |
| Shares Outstanding | 94.38M |
| Shares Change (YoY) | +21.44% |
| Shares Change (QoQ) | +0.63% |
| Owned by Insiders (%) | 3.56% |
| Owned by Institutions (%) | 96.38% |
| Float | 90.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.84 |
| Forward PS | 5.08 |
| PB Ratio | 23.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 5.88.
| Current Ratio | 2.40 |
| Quick Ratio | 2.05 |
| Debt / Equity | 5.88 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.35 |
Financial Efficiency
Return on equity (ROE) is -377.06% and return on invested capital (ROIC) is -30.38%.
| Return on Equity (ROE) | -377.06% |
| Return on Assets (ROA) | -24.51% |
| Return on Invested Capital (ROIC) | -30.38% |
| Return on Capital Employed (ROCE) | -50.34% |
| Revenue Per Employee | $456,483 |
| Profits Per Employee | -$424,713 |
| Employee Count | 1,294 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 18.87 |
Taxes
In the past 12 months, RARE has paid $2.45 million in taxes.
| Income Tax | 2.45M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.34% in the last 52 weeks. The beta is 0.24, so RARE's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -10.34% |
| 50-Day Moving Average | 35.79 |
| 200-Day Moving Average | 44.98 |
| Relative Strength Index (RSI) | 55.65 |
| Average Volume (20 Days) | 973,960 |
Short Selling Information
The latest short interest is 5.89 million, so 6.24% of the outstanding shares have been sold short.
| Short Interest | 5.89M |
| Short Previous Month | 5.54M |
| Short % of Shares Out | 6.24% |
| Short % of Float | 6.48% |
| Short Ratio (days to cover) | 6.08 |
Income Statement
In the last 12 months, RARE had revenue of $590.69 million and -$549.58 million in losses. Loss per share was -$5.88.
| Revenue | 590.69M |
| Gross Profit | -182.32M |
| Operating Income | -513.57M |
| Pretax Income | -586.86M |
| Net Income | -549.58M |
| EBITDA | -477.88M |
| EBIT | -513.57M |
| Loss Per Share | -$5.88 |
Full Income StatementBalance Sheet
The company has $494.44 million in cash and $889.70 million in debt, giving a net cash position of -$326.69 million or -$3.46 per share.
| Cash & Cash Equivalents | 494.44M |
| Total Debt | 889.70M |
| Net Cash | -326.69M |
| Net Cash Per Share | -$3.46 |
| Equity (Book Value) | 151.25M |
| Book Value Per Share | 1.54 |
| Working Capital | 407.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$389.94 million and capital expenditures -$5.60 million, giving a free cash flow of -$395.54 million.
| Operating Cash Flow | -389.94M |
| Capital Expenditures | -5.60M |
| Free Cash Flow | -395.54M |
| FCF Per Share | -$4.19 |
Full Cash Flow StatementMargins
Gross margin is -30.87%, with operating and profit margins of -86.94% and -93.04%.
| Gross Margin | -30.87% |
| Operating Margin | -86.94% |
| Pretax Margin | -92.63% |
| Profit Margin | -93.04% |
| EBITDA Margin | -80.90% |
| EBIT Margin | -86.94% |
| FCF Margin | n/a |
Dividends & Yields
RARE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.44% |
| Shareholder Yield | -21.44% |
| Earnings Yield | -15.67% |
| FCF Yield | -11.28% |
Dividend DetailsAnalyst Forecast
The average price target for RARE is $92.29, which is 148.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $92.29 |
| Price Target Difference | 148.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 35.12% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RARE has an Altman Z-Score of -2.69 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.69 |
| Piotroski F-Score | 4 |